Dr. David Dunner, MD

NPI: 1023188463
Total Payments
$121,344
2024 Payments
$16,790
Companies
27
Transactions
536

Payment Breakdown by Category

Other$44,713 (36.8%)
Consulting$30,203 (24.9%)
Research$27,550 (22.7%)
Food & Beverage$11,590 (9.6%)
Travel$7,115 (5.9%)
Education$173.25 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $44,713 20 36.8%
Consulting Fee $30,203 12 24.9%
Unspecified $27,550 8 22.7%
Food and Beverage $11,590 454 9.6%
Travel and Lodging $7,115 36 5.9%
Education $173.25 6 0.1%

Payments by Type

General
$93,794
528 transactions
Research
$27,550
8 transactions

Top Paying Companies

Company Total Records Latest Year
Janssen Pharmaceuticals, Inc $53,436 98 $0 (2024)
LivaNova USA, Inc. $31,057 42 $0 (2024)
Janssen Scientific Affairs, LLC $15,807 17 $0 (2024)
Alkermes, Inc. $8,334 15 $0 (2023)
Otsuka Pharmaceutical Development & Commercialization, Inc. $6,177 8 $0 (2017)
Otsuka America Pharmaceutical, Inc. $964.69 59 $0 (2024)
Teva Pharmaceuticals USA, Inc. $801.21 40 $0 (2024)
ABBVIE INC. $788.65 47 $0 (2024)
ITI, Inc. $656.87 40 $0 (2023)
Neurocrine Biosciences, Inc. $586.25 22 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $16,790 119 Janssen Scientific Affairs, LLC ($14,569)
2023 $3,156 94 Janssen Scientific Affairs, LLC ($1,239)
2022 $1,825 68 LivaNova USA, Inc. ($778.46)
2021 $1,077 43 LivaNova USA, Inc. ($248.09)
2020 $30,757 38 LivaNova USA, Inc. ($27,694)
2019 $51,333 109 Janssen Pharmaceuticals, Inc ($49,323)
2018 $8,851 30 Alkermes, Inc. ($8,147)
2017 $7,554 35 Otsuka Pharmaceutical Development & Commercialization, Inc. ($6,177)

All Payment Transactions

536 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $25.77 General
Category: PSYCHIATRY
12/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $39.73 General
Category: Neuropsychiatry
12/16/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $1.84 General
Category: Neuropsychiatry
12/10/2024 Neurocrine Biosciences, Inc. Food and Beverage In-kind items and services $35.04 General
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Consulting Fee Cash or cash equivalent $8,437.50 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Travel and Lodging In-kind items and services $549.00 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Travel and Lodging In-kind items and services $111.63 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Travel and Lodging Cash or cash equivalent $74.00 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Food and Beverage In-kind items and services $64.95 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Travel and Lodging Cash or cash equivalent $33.50 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Food and Beverage Cash or cash equivalent $24.02 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Food and Beverage Cash or cash equivalent $16.92 General
Category: Neuroscience
12/02/2024 Janssen Scientific Affairs, LLC SPRAVATO (Drug) Food and Beverage In-kind items and services $13.95 General
Category: Neuroscience
11/26/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $18.41 General
Category: PSYCHIATRY
11/19/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $4.19 General
Category: NEUROSCIENCE
11/18/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $1.06 General
Category: NEUROSCIENCE
11/12/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $24.64 General
Category: PSYCHIATRY
11/06/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $25.75 General
Category: PSYCHIATRY
11/04/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $21.08 General
Category: PSYCHIATRY
10/22/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $26.82 General
Category: PSYCHIATRY
10/17/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $29.93 General
Category: Neuroscience
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.13 General
Category: NEUROSCIENCE
10/16/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $3.85 General
Category: NEUROSCIENCE
10/15/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $27.08 General
Category: PSYCHIATRY
10/08/2024 Noven Therapeutics, LLC Xelstrym (Drug), Secuado Food and Beverage In-kind items and services $20.99 General
Category: ADHD

Research Studies & Clinical Trials

Study Name Company Amount Records
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression LivaNova USA, Inc. $27,550 8

About Dr. David Dunner, MD

Dr. David Dunner, MD is a Psychiatry healthcare provider based in Mercer Island, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023188463.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dunner, MD has received a total of $121,344 in payments from pharmaceutical and medical device companies, with $16,790 received in 2024. These payments were reported across 536 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,713).

Practice Information

  • Specialty Psychiatry
  • Location Mercer Island, WA
  • Active Since 11/09/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1023188463

Products in Payments

  • SPRAVATO (Drug) $68,362
  • VNS Therapy (Device) $29,490
  • ABILIFY MAINTENA (Drug) $5,108
  • REXULTI (Drug) $1,124
  • ABILIFY TABLET (Drug) $1,090
  • VRAYLAR (Drug) $1,006
  • CAPLYTA (Drug) $997.05
  • VNS Therapy Symmetry Model 8103 Generator (Device) $778.46
  • AUSTEDO (Drug) $594.66
  • INGREZZA (Drug) $551.21
  • VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $540.49
  • VNS - Symmetry (Device) $248.09
  • TRINTELLIX (Drug) $244.84
  • QUVIVIQ (Drug) $186.89
  • Trintellix (Drug) $168.65
  • Auvelity (Drug) $166.77
  • NeuroStar TMS Therapy (Device) $157.61
  • NUEDEXTA (Drug) $143.85
  • LATUDA (Drug) $133.23
  • LYBALVI (Drug) $120.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Mercer Island